Effects of resveratrol supplementation on liver enzymes: A systematic review and meta‐analysis of randomised controlled trials
出版年份 2020 全文链接
标题
Effects of resveratrol supplementation on liver enzymes: A systematic review and meta‐analysis of randomised controlled trials
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-09-01
DOI
10.1111/ijcp.13692
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global Liver Disease Burdens and Research Trends: Analysis from a China Perspective
- (2019) Jia Xiao et al. JOURNAL OF HEPATOLOGY
- Influence of Resveratrol on the Immune Response
- (2019) Malaguarnera Nutrients
- Resveratrol: a review of plant sources, synthesis, stability, modification and food application
- (2019) Bingren Tian et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
- (2018) ShadiSadat Seyyedebrahimi et al. ACTA DIABETOLOGICA
- Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial
- (2018) Konstantinos Kantartzis et al. DIABETES OBESITY & METABOLISM
- Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
- (2018) Somayyeh Asghari et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind placebo-controlled trial
- (2018) Luis E. Simental-Mendía et al. NUTRITION
- No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial
- (2017) Thomas Nordstrøm Kjær et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance
- (2017) Manuela Pennisi et al. Nutrients
- Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases
- (2016) Allan Lançon et al. MOLECULES
- Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
- (2016) Sara Heebøll et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Resveratrol Protects Against Methotrexate-Induced Hepatic Injury in Rats
- (2016) Tugba Tunalı-Akbay et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
- (2016) Chongyang Zhang et al. PLoS One
- Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
- (2015) Beshay N.M. Zordoky et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
- (2015) Forouzan Faghihzadeh et al. BRITISH JOURNAL OF NUTRITION
- Effects of chronic resveratrol supplementation in military firefighters undergo a physical fitness test – A placebo-controlled, double blind study
- (2015) R.C.S. Macedo et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- Resveratrol and liver: A systematic review
- (2015) Payman Adibi et al. Journal of Research in Medical Sciences
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study
- (2014) Stephen D. Anton et al. EXPERIMENTAL GERONTOLOGY
- Effects of Resveratrol in Patients with Type 2 Diabetes Mellitus on Skeletal Muscle SIRT1 Expression and Energy Expenditure
- (2014) Kian Peng Goh et al. INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients
- (2013) Ali Movahed et al. Evidence-based Complementary and Alternative Medicine
- Resveratrol Improves Vascular Function in Patients With Hypertension and Dyslipidemia by Modulating NO Metabolism
- (2013) Albino Carrizzo et al. HYPERTENSION
- Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation
- (2013) João Marcus Oliveira Andrade et al. NUTRITION
- Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet–induced obesity
- (2013) Bin Wang et al. NUTRITION RESEARCH
- One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease
- (2013) João Tomé-Carneiro et al. PHARMACOLOGICAL RESEARCH
- Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers
- (2012) María Isabel Queipo-Ortuño et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Resveratrol, A Neuroprotective Supplement for Alzheimer's Disease
- (2012) Fei Li et al. CURRENT PHARMACEUTICAL DESIGN
- High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
- (2012) M. M. Poulsen et al. DIABETES
- Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats
- (2011) Roberta Schmatz et al. BIOCHIMIE
- Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress
- (2011) S. Gómez-Zorita et al. BRITISH JOURNAL OF NUTRITION
- Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
- (2011) Pál Brasnyó et al. BRITISH JOURNAL OF NUTRITION
- Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats
- (2010) Eun-Sil Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats
- (2010) Sang-Won Hong et al. ARCHIVES OF PHARMACAL RESEARCH
- SIRT1 Takes a Backseat to AMPK in the Regulation of Insulin Sensitivity by Resveratrol
- (2010) M. D. Fullerton et al. DIABETES
- Anti-inflammatory activities of resveratrol in the brain: Role of resveratrol in microglial activation
- (2010) Feng Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Antioxidant properties of resveratrol: A structure–activity insight
- (2009) İlhami Gülçin Innovative Food Science & Emerging Technologies
- Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
- (2008) Jing SHANG et al. ACTA PHARMACOLOGICA SINICA
- Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats
- (2008) Jeng-Feng Lin et al. LIFE SCIENCES
- Beneficial drugs for liver diseases
- (2007) Pablo Muriel et al. JOURNAL OF APPLIED TOXICOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now